Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Revenue

Mankind Pharma had revenue of 40.31B INR in the quarter ending June 30, 2026, with 12.89% growth. This brings the company's revenue in the last twelve months to 147.38B, up 14.16% year-over-year. In the fiscal year ending March 31, 2026, Mankind Pharma had annual revenue of 142.78B with 16.96% growth.

• Revenue (ttm): 147.38B
• Revenue Growth: +14.16%
• P/S Ratio: 6.68
• Revenue / Employee: 7.21M
• Employees: 20,451
• Market Cap: 984.58B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	142.78B	20.70B	16.96%
Mar 31, 2025	122.07B	19.47B	18.98%
Mar 31, 2024	102.60B	15.11B	17.27%
Mar 31, 2023	87.49B	9.68B	12.44%
Mar 31, 2022	77.82B	15.67B	25.22%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error